Created at Source Raw Value Validated value
Feb. 2, 2022, 1 p.m. usa

inclusion criteria: 18 ≤age ≤59 years; vaccinated with two doses of sars-cov-2 vaccine (manufactured by sino biopharmaceutical limited or sinovac biotech co., ltd.) (≥6 months from the time of vaccination). not vaccinated third dose vaccination; voluntarily participate in the study with signed informed consent form.

inclusion criteria: 18 ≤age ≤59 years; vaccinated with two doses of sars-cov-2 vaccine (manufactured by sino biopharmaceutical limited or sinovac biotech co., ltd.) (≥6 months from the time of vaccination). not vaccinated third dose vaccination; voluntarily participate in the study with signed informed consent form.

Jan. 20, 2022, 11:30 a.m. usa

inclusion criteria: 18 ≥age ≥59 years; vaccinated with two doses of sars-cov-2 vaccine (manufactured by sino biopharmaceutical limited or sinovac biotech co., ltd.) (≥6 months from the time of vaccination). not vaccinated third dose vaccination; voluntarily participate in the study with signed informed consent form.

inclusion criteria: 18 ≥age ≥59 years; vaccinated with two doses of sars-cov-2 vaccine (manufactured by sino biopharmaceutical limited or sinovac biotech co., ltd.) (≥6 months from the time of vaccination). not vaccinated third dose vaccination; voluntarily participate in the study with signed informed consent form.